Update on Benzene in Dermatology Products

Masterclasses in Dermatology

C. Bunick

Treatment Strategies for Hematocrit Control in PV

Insights from 2023 ASH Annual Meeting

A. Zhou

Increasing Melanoma Incidence with Unchanged Mortality, 1999 - 2019

Jesper Bo Nielsen

What's Hot (Not) in (HIV) Primary Care

UCSF School of Medicine

C. Bositis, J. Bloome

Safety Profile of Ruxolitinib in Patients With MF

Icahn School of Medicine at Mount Sinai

D. Tremblay

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Insights from 2023 ASH Annual Meeting

D. Tremblay

Focusing on Flow: PSA Screening in PWH

UCSF School of Medicine

H. Patel

EADV 2023 Insights: How to Avoid Mistreatment of Neoplastic Lesions

EADV 2023 Insights

I. Zalaudek

Hematologic Malignancies: From Clotting to Bleeding

Medical College of Georgia - Augusta University

G. Raval

Treatment-Related Quality of Life in MF

Winship Cancer Institute - Emory University

A. Hunter

Leukemia Tumor Board at the Tisch Cancer Institute at Mount Sinai: 6…

Tisch Cancer Institute at Mount Sinai

M. Metzger

Diagnosis and Goals of Therapy in PV

Northwestern Medicine Oncology and Hematology

B. Stein

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

ASH 2022 Conference Coverage

M. McMullin

COVID-19 and the Risk of Autoimmune Disease, Including Alopecia Area…

Evidence-Based Hair

J. Donovan

How to Manage: Melanonychia

EADV 2022 Conference Coverage

M. Starace

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

Monia Marchetti

EADV 2022: Microbiota and Biofilms in Hidradenitis Suppurativa

EADV 2022 Conference Coverage

A. Nassif

SOHO 2021 Next Questions in ALL

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

B. Shah

Repurposing Mitochondria-Protective Targets for Adjuvant IBD Therapy

UEG - United European Gastroenterology

D. Haller

2020 Update on Blood Cancer Diagnosis: Morphology, Cytogenetic/Molec…

GRACE

M. Ruiz